By both competitively inhibiting BH3 binding at the groove, and promoting degradation in cells, the small molecules dramatically reduce MCL‐1 activity in treated cells, promoting apoptosis in MCL‐1 dependent cancer cell lines. This evidence concerns the gene MCL1 and cancer.